Skip to main content


Curated genomics data to advance discovery and treatment

Watch Dr. Ashley Brenton, VP, real-world evidence and genomics, Optum Life Sciences, discuss patient journeys and cohort building.

Get a more complete patient journey with Optum data


There are many situations where a patient is diagnosed in one setting and treated in another. As Dr. Brenton discusses in the webinar clip, data sets exclusive to one specialty area may miss critical details found in other clinical records.

That’s why Optum clinicogenomic data span specialties and sites of care. Our data provide insight into patient journeys from pre-diagnosis through treatment and beyond. This provides a more holistic understanding of care decisions and outcomes. 

Build meaningful cohorts across disease areas


You need relevant, overlapping claims, clinical and genomic data to build a clinicogenomic cohort that will bring value to your research. Sometimes a small, highly specialized data set does the trick. At other times, you may need a larger sample.

In this webinar clip, Dr. Brenton talks about important considerations for building longitudinal clinicogenomic data cohorts and the importance of diversity in the data. 

Discover the potential of genomic data

Interested in learning more about the value of clinicogenomic data? Contact us today.

Related content

Clinicogenomics: new, linked data is advancing research

Rich, longitudinal clinicogenomics data can fuel all stages of drug development.

Catalyze the use of RWE in the life sciences industry

Discover how using real-world evidence (RWE) in the life sciences industry can help catapult learning and drive impact for your company.

Realizing the full potential of clinicogenomics

Join Optum genomics experts as they discuss the progress being made to develop datasets that will aid in drug discovery and development.